South African ports handling more boxes, but challenges remain
Despite handling the highest throughput since 2017/18, South Africa’s ports last week continued beset by ...
WTC: ANOTHER DIFFICULT WEEK CHRW: NEW PRODUCT LAUNCHDSV: LEADING THE DROP RXO: CRATERINGDSV: WHAT TO LIKEDSV: BULLISH BAMZN: 'AI EDGE'HD: HERE IS HOW IT LOOKSAMZN: REG RISKMAERSK: MOST HARMED
WTC: ANOTHER DIFFICULT WEEK CHRW: NEW PRODUCT LAUNCHDSV: LEADING THE DROP RXO: CRATERINGDSV: WHAT TO LIKEDSV: BULLISH BAMZN: 'AI EDGE'HD: HERE IS HOW IT LOOKSAMZN: REG RISKMAERSK: MOST HARMED
|
14 October 2016 Cipla BioTec and Dube TradePort will be building Africa’s first fully integrated biopharmaceutical plant to make biopharmaceuticals within Dube TradePort Special Economic Zone in KwaZulu-Natal. The parties previously on the 8th July 2016 announced the overall investment level for manufacturing and development costs and it is targeted to be approximately R 1,3 billion. The two parties signed a Memorandum of Understanding for the commercial terms at a meeting in Goa, India on the 14th October 2016. |
For uninterrupted access, sign in or sign up to The Daily News, Premium or The Loadstar Enterprise Plan.
Comment on this article